Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 13/20 | 0.45 |
| ▸ | LYN | P07948 | 1/20 | 0.43 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.43 |
| ▸ | SMO | Q99835 | 3/20 | 0.43 |
| ▸ | SRC | P12931 | 5/20 | 0.43 |
| ▸ | SYK | P43405 | 5/20 | 0.43 |
| ▸ | GSK3A | P49840 | 4/20 | 0.43 |
| ▸ | LCK | P06239 | 2/20 | 0.43 |
| ▸ | BRAF | P15056 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4416273 | 0.90 | MAPK14 (0.41) | MAPK14SMOSRCSYKGSK3A | |
| SCHEMBL2843245 | 0.88 | MAPK14 (0.46) | MAPK14LYNMAPK9SRCSYK | |
| SCHEMBL5487370 | 0.88 | MAPK14 (0.44) | MAPK14SMOGSK3A | |
| SCHEMBL5486377 | 0.87 | MAPK14 (0.44) | MAPK14SMO | |
| SCHEMBL14534467 | 0.86 | NR1H4 (0.49) | MAPK14SMO | |
| SCHEMBL4417658 | 0.81 | MAPT (0.42) | MAPK14SMOSRCSYKGSK3A | |
| SCHEMBL4408412 | 0.78 | MAPK14 (0.44) | MAPK14SMO | |
| SCHEMBL4417851 | 0.78 | MAPK14 (0.44) | MAPK14SRCSYKGSK3ALCK | |
| SCHEMBL5490019 | 0.78 | RAB9A (0.42) | MAPK14GSK3ATRPV1 | |
| SCHEMBL4408299 | 0.78 | MAPK14 (0.42) | MAPK14SRCSYKGSK3ALCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2227453-B1 | HETEROARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS | VERTEX PHARMA (US) | 2016-03-09 | — | — | EP | disclosed |
| EP-2227453-A2 | HETEROARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS | Vertex Pharmaceuticals Incorporated (US) | 2010-09-15 | — | — | EP | disclosed |
| WO-2009049180-A2 | HETEROARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2009-04-16 | — | — | WO | disclosed |